• Isolated mitochondria from
Rodent organs (Liver, Heart, Kidney)
Differentiated human cells (HepaRG®)
• Cultured human cells
Primary cells (Hepatocytes, Fibroblasts, PBMC)
iPS-derived cardiomyocytes (Cor.4U®)
Hepatic stem cell line (HepaRG®)
*Porceddu et al., Toxicol Sci., 2012.
You are a pharmaceutical industry or a biotechnology company and you want to evaluate the toxicity potential of your drugs or your compounds prior to enter into preclinical regulatory stage.
Mitologics highly predictive toxicity assays using platform are for you :
Starting Module
• Acute/direct mitochondrial toxicity (on isolated mitochondria)
Swelling
Transmembrane potential
O2 consumption driven by complex I or II
• Short term (or metabolites) mitochondrial toxicity (on cultured cells)
Viability or whole ATP content
Transmembrane potential
Global respiration
ROS production
Premium module
• Acute/direct mitochondrial toxicity (on isolated mitochondria)
Fatty acids ß-oxidation
Complex (I-IV) enzymatic activity
ROS production
ATP production
• Long term mitochondrial toxicity (on cultured cells)
Viability or whole ATP content
Transmembrane potential
Global respiration
mtDNA quantification
PRECLINICAL STUDIES
ONCOLOGY
ORGANOPROTECTION
CARDIOPROTECTION
DRUG DISCOVERIES
CARDIOTOXICITY
HEPATOTOXICITY
DILI
NON TOXIC COMPOUNDS
COMPOUND SAFETY
SLIMMING
ANTI-AGING
TOXICITY PROFILING
CONTAMINANT EFFECTS
MITOCHONDRIA
RESPIRATION
OXIDATIVE STRESS
APOPTOSIS
HEPARG®